Texas A&M Institute of Biosciences and Technology

Texas A&M Institute of Biosciences and Technology To advance knowledge and technology in bioscience and the health professions through innovative rese IBT students pursue a Ph.D.

From cancer and heart failure to bacterial infections and birth defects, researchers at the Texas A&M Health Science Center Institute of Biosciences & Technology in Houston work to improve the quality of health care through innovative research and education. The institute is organized into Centers of research excellence in cancer, genomics and disease, developmental biology and birth defects, and

infectious disease. Graduate and postdoctoral education is conducted at the Institute of Biosciences and Technology as part of the Texas A&M Health Science Center Graduate Program. in the Graduate Program in Medical Sciences.

Proud moment for the Institute of Biosciences and Technology at Texas A&M University Health!A new feature article in Dru...
05/11/2026

Proud moment for the Institute of Biosciences and Technology at Texas A&M University Health!

A new feature article in Drug Discovery Today (May 2026) showcases Texas’s groundbreaking multi-institutional model for academic drug discovery: “A statewide multi-institutional model that de-risks academic drug discovery.”

Led by Suzanne Tomlinson-Mathis and the IDDD Core Network, the article highlights the collaborative power of cores across Texas — including three key contributors from IBT: Peter Davies, Clifford Stephan, and Margie Moczygemba.

This network has supported more than 750 projects, launched 60+ startups, advanced 15 programs into the clinic, and attracted nearly $1 billion in follow-on funding.

Full open-access article:
https://bit.ly/4nkq1Jw

Please access soon — the link provides immediate full text, but some viewing windows can be limited.

We are honored that IBT is recognized as a vital part of this successful, replicable model that accelerates discoveries from bench to bedside.

Texas A&M researcher Dr. Praveen Rajendran secures $1.32M from NCI PREVENT to study low-dose drug combinations targeting...
12/15/2025

Texas A&M researcher Dr. Praveen Rajendran secures $1.32M from NCI PREVENT to study low-dose drug combinations targeting colitis-associated colorectal cancer, in collaboration with Drs. Dashwood (Texas A&M) & Vilar-Sanchez (MD Anderson).

Texas A&M Institute of Biosciences and Technology is proud to announce that Dr. Jiang Chang has been selected as the 202...
11/26/2025

Texas A&M Institute of Biosciences and Technology is proud to announce that Dr. Jiang Chang has been selected as the 2025 Thomas Smith Memorial Lecturer by the American Heart Association. This lecture was established in 1997 by the Council on Basic Science to honor Dr. Thomas W. Smith, a pioneer in the application of biochemical, cellular, and molecular approaches to investigative cardiac contractility. The lecture is presented annually at the American Heart Association's Scientific Sessions. Join us in congratulating Dr. Chang on this wonderful recognition! https://bit.ly/3JZ4V4u

Texas A&M Institute of Biosciences and Technology is proud to announce Dr. Wenshe Liu as a 2025 Regents Professor Award ...
11/25/2025

Texas A&M Institute of Biosciences and Technology is proud to announce Dr. Wenshe Liu as a 2025 Regents Professor Award Winner. The Regents Professor Award program honors individuals at the rank of professor or equivalent whose outstanding performance in teaching, research, and service has been exemplary and whose achievements impact not only their institution or agency but also the community, the state of Texas, and/or national and international levels. Congratulations Dr. Liu on this impressive honor! https://facultyaffairs.tamu.edu/elevate-your-impact/faculty-awards-recognition/university-awards/the-regents-professors.html

08/18/2025

Discover Texas A&M Health's impactful presence in the Medical Center! In our latest video, "Dr. Ramos on Texas A&M Health Institute of Biosciences and Technology’s Mission," our Executive Director shares our dedication to advancing health through groundbreaking research.

A huge thank you to our incredible sponsors for supporting our research and making the 2025 GSO Research Symposium possi...
05/13/2025

A huge thank you to our incredible sponsors for supporting our research and making the 2025 GSO Research Symposium possible!

Our annual GSO Research Symposium celebrates the incredible research of our students and postdocs! We were honored to we...
05/13/2025

Our annual GSO Research Symposium celebrates the incredible research of our students and postdocs! We were honored to welcome astronaut Dr. Kate Rubins as our keynote speaker. Join us in recognizing the achievements of this year’s winners!

🎤 Oral presentations:
1st: Jimmy Wengler
2nd: Logan Rivera
3rd: Thomas Wong and Yingshan Wang

📊 Poster presentations:
1st: Sokviseth Moeng
2nd: Heather Barreda
3rd: Javier Villela

1st Place Post-doc Oral: Tien-Hung Lan
1st Place Post-doc Poster: Tianlu Wang

🎉 Big News from IBT! 🎉 Congrats to Dr. Kenneth Ramos on being named a 2025 Texas A&M University Distinguished Professor—...
02/12/2025

🎉 Big News from IBT! 🎉 Congrats to Dr. Kenneth Ramos on being named a 2025 Texas A&M University Distinguished Professor—the highest faculty honor! Their transformative work drives innovation in biosciences & medicine.

🔗 Learn more: https://bit.ly/4aNNVXG

Alkek Building ReopeningI am pleased to inform you that the Alkek Building will resume normal operations on Thursday, Ja...
01/22/2025

Alkek Building Reopening
I am pleased to inform you that the Alkek Building will resume normal operations on Thursday, January 23rd, 2025.

Address

2121 W. Holcombe Boulevard
Houston, TX
77030

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17136777700

Alerts

Be the first to know and let us send you an email when Texas A&M Institute of Biosciences and Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share